Precision dosing and personalized medicine in pediatric inflammatory bowel disease

R.J. Colman

Precision dosing and personalized medicine in pediatric inflammatory bowel disease

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

Children with inflammatory bowel disease (IBD) have a chronic progressive gastrointestinal illness with significant morbidity and disease complications if not adequately treated. As treatments are often not extensively studied in children and there is a significant delay in regulatory approval for the pediatric age, there are limited treatment options available for children with IBD. This

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	D' Haens, Geert, Supervisor van Limbergen, Johan, Co-supervisor
Award date	14 Jun 2023
Print ISBNs	9789464197921
Publication status	Published - 14 Jun 2023

Access to Document

Cite this

@phdthesis{29da0149c02f46f58de5ced5214f1aee,

title = "Precision dosing and personalized medicine in pediatric inflammatory bowel disease",

abstract = "Children with inflammatory bowel disease (IBD) have a chronic progressive gastrointestinal illness with significant morbidity and disease complications if not adequately treated. As treatments are often not extensively studied in children and there is a significant delay in regulatory approval for the pediatric age, there are limited treatment options available for children with IBD. This",

author = "R.J. Colman",

year = "2023",

month = jun,

day = "14",

language = "English",

isbn = "9789464197921",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - Precision dosing and personalized medicine in pediatric inflammatory bowel disease

AU - Colman, R.J.

PY - 2023/6/14

Y1 - 2023/6/14

N2 - Children with inflammatory bowel disease (IBD) have a chronic progressive gastrointestinal illness with significant morbidity and disease complications if not adequately treated. As treatments are often not extensively studied in children and there is a significant delay in regulatory approval for the pediatric age, there are limited treatment options available for children with IBD. This

AB - Children with inflammatory bowel disease (IBD) have a chronic progressive gastrointestinal illness with significant morbidity and disease complications if not adequately treated. As treatments are often not extensively studied in children and there is a significant delay in regulatory approval for the pediatric age, there are limited treatment options available for children with IBD. This

UR - https://pure.uva.nl/ws/files/127083967/Stellingen.pdf

UR - https://pure.uva.nl/ws/files/127083969/Licentieovereenkomst_medeondertekend_.pdf

M3 - Phd-Thesis - Research and graduation internal

SN - 9789464197921

ER -

Precision dosing and personalized medicine in pediatric inflammatory bowel disease

Abstract

Access to Document

Other files and links

Cite this